BACKGROUND: Bipolar I disorder is a highly heritable psychiatric illness with undetermined predisposing genetic and environmental risk factors. We examined familial contributions to hippocampal morphology in bipolar disorder, using a population-based twin cohort design. METHODS: We acquired high-resolution brain MRI scans from 18 adult patients with bipolar I disorder [BPI; mean age 45.6 ± 8.69 (SD); 10 lithium-treated], 14 non-bipolar co-twins, and 32 demographically matched healthy comparison twins. We used three-dimensional radial distance mapping techniques to visualize hippocampal shape differences between groups. RESULTS: Lithium-treated BPI patients had significantly larger global hippocampal volume compared to both healthy controls (9%) and non-bipolar co-twins (12%), and trend-level larger volumes relative to non-lithium-treated BPI patients (8%). In contrast, hippocampal volumes in non-lithium-treated BPI patients did not differ from those of non-bipolar co-twins and control twins. 3D surface maps revealed thicker hippocampi in lithium-treated BPI probands compared with control twins across the entire anterior-to-posterior extent of the cornu ammonis (CA1 and 2) regions, and the anterior part of the subiculum. Unexpectedly, co-twins also showed significantly thicker hippocampi compared with control twins in regions that partially overlapped those showing effects in the lithium treated BPI probands. CONCLUSIONS: These findings suggest that regionally thickened hippocampi in bipolar I disorder may be partly due to familial factors and partly due to lithium-induced neurotrophy, neurogenesis, or neuroprotection. Unlike schizophrenia, hippocampal alterations in co-twins of bipolar I disorder probands are likely to manifest as subtle volume excess rather than deficit, perhaps indicating protective rather than risk effects.
BACKGROUND:Bipolar I disorder is a highly heritable psychiatric illness with undetermined predisposing genetic and environmental risk factors. We examined familial contributions to hippocampal morphology in bipolar disorder, using a population-based twin cohort design. METHODS: We acquired high-resolution brain MRI scans from 18 adult patients with bipolar I disorder [BPI; mean age 45.6 ± 8.69 (SD); 10 lithium-treated], 14 non-bipolar co-twins, and 32 demographically matched healthy comparison twins. We used three-dimensional radial distance mapping techniques to visualize hippocampal shape differences between groups. RESULTS:Lithium-treated BPIpatients had significantly larger global hippocampal volume compared to both healthy controls (9%) and non-bipolar co-twins (12%), and trend-level larger volumes relative to non-lithium-treated BPIpatients (8%). In contrast, hippocampal volumes in non-lithium-treated BPIpatients did not differ from those of non-bipolar co-twins and control twins. 3D surface maps revealed thicker hippocampi in lithium-treated BPI probands compared with control twins across the entire anterior-to-posterior extent of the cornu ammonis (CA1 and 2) regions, and the anterior part of the subiculum. Unexpectedly, co-twins also showed significantly thicker hippocampi compared with control twins in regions that partially overlapped those showing effects in the lithium treated BPI probands. CONCLUSIONS: These findings suggest that regionally thickened hippocampi in bipolar I disorder may be partly due to familial factors and partly due to lithium-induced neurotrophy, neurogenesis, or neuroprotection. Unlike schizophrenia, hippocampal alterations in co-twins of bipolar I disorder probands are likely to manifest as subtle volume excess rather than deficit, perhaps indicating protective rather than risk effects.
Authors: E T Bullmore; J Suckling; S Overmeyer; S Rabe-Hesketh; E Taylor; M J Brammer Journal: IEEE Trans Med Imaging Date: 1999-01 Impact factor: 10.048
Authors: L L Altshuler; G Bartzokis; T Grieder; J Curran; T Jimenez; K Leight; J Wilkins; R Gerner; J Mintz Journal: Biol Psychiatry Date: 2000-07-15 Impact factor: 13.382
Authors: M L Gourovitch; E F Torrey; J M Gold; C Randolph; D R Weinberger; T E Goldberg Journal: Biol Psychiatry Date: 1999-03-01 Impact factor: 13.382
Authors: T D Cannon; M O Huttunen; J Lonnqvist; A Tuulio-Henriksson; T Pirkola; D Glahn; J Finkelstein; M Hietanen; J Kaprio; M Koskenvuo Journal: Am J Hum Genet Date: 2000-07-03 Impact factor: 11.025
Authors: A G Cardno; E J Marshall; B Coid; A M Macdonald; T R Ribchester; N J Davies; P Venturi; L A Jones; S W Lewis; P C Sham; I I Gottesman; A E Farmer; P McGuffin; A M Reveley; R M Murray Journal: Arch Gen Psychiatry Date: 1999-02
Authors: Suzanne N Avery; Lisa E Williams; Austin A Woolard; Stephan Heckers Journal: Eur Arch Psychiatry Clin Neurosci Date: 2013-09-11 Impact factor: 5.270
Authors: Ariel G Gildengers; Meryl A Butters; Howard J Aizenstein; Megan M Marron; James Emanuel; Stewart J Anderson; Lisa A Weissfeld; James T Becker; Oscar L Lopez; Benoit H Mulsant; Charles F Reynolds Journal: Bipolar Disord Date: 2014-09-25 Impact factor: 6.744
Authors: Katherine E Burdick; Caitlin E Millett; Manuela Russo; Martin Alda; Ney Alliey-Rodriguez; Amit Anand; Yokesh Balaraman; Wade Berrettini; Holli Bertram; Joseph R Calabrese; Cynthia Calkin; Carla Conroy; William Coryell; Anna DeModena; Scott Feeder; Carrie Fisher; Nicole Frazier; Mark Frye; Keming Gao; Julie Garnham; Elliot S Gershon; Kara Glazer; Fernando S Goes; Toyomi Goto; Gloria J Harrington; Petter Jakobsen; Masoud Kamali; Marisa Kelly; Susan Leckband; Else Marie Løberg; Falk W Lohoff; Adam X Maihofer; Michael J McCarthy; Melvin McInnis; Gunnar Morken; Caroline M Nievergelt; John Nurnberger; Ketil J Oedegaard; Abigail Ortiz; Megan Ritchey; Kelly Ryan; Martha Schinagle; Candice Schwebel; Martha Shaw; Paul Shilling; Claire Slaney; Emma Stapp; Bruce Tarwater; Peter Zandi; John R Kelsoe Journal: Neuropsychopharmacology Date: 2020-04-29 Impact factor: 7.853
Authors: Bo Cao; Isabelle E Bauer; Ajaykumar N Sharma; Benson Mwangi; Thomas Frazier; Luca Lavagnino; Giovana B Zunta-Soares; Consuelo Walss-Bass; David C Glahn; Flavio Kapczinski; David A Nielsen; Jair C Soares Journal: J Affect Disord Date: 2016-03-10 Impact factor: 4.839
Authors: Orestes V Forlenza; Artur Martins Novaes Coutinho; Ivan Aprahamian; Silvana Prando; Luciana Lucas Mendes; Breno S Diniz; Wagner F Gattaz; Carlos A Buchpiguel Journal: ACS Chem Neurosci Date: 2014-04-29 Impact factor: 4.418